US20100176306A1 - Implantation quality improvement by xenon/hydrogen dilution gas - Google Patents
Implantation quality improvement by xenon/hydrogen dilution gas Download PDFInfo
- Publication number
- US20100176306A1 US20100176306A1 US12/416,725 US41672509A US2010176306A1 US 20100176306 A1 US20100176306 A1 US 20100176306A1 US 41672509 A US41672509 A US 41672509A US 2010176306 A1 US2010176306 A1 US 2010176306A1
- Authority
- US
- United States
- Prior art keywords
- dilutant
- dopant gas
- dopant
- xenon
- diluted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J37/00—Discharge tubes with provision for introducing objects or material to be exposed to the discharge, e.g. for the purpose of examination or processing thereof
- H01J37/02—Details
- H01J37/04—Arrangements of electrodes and associated parts for generating or controlling the discharge, e.g. electron-optical arrangement, ion-optical arrangement
- H01J37/08—Ion sources; Ion guns
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J37/00—Discharge tubes with provision for introducing objects or material to be exposed to the discharge, e.g. for the purpose of examination or processing thereof
- H01J37/30—Electron-beam or ion-beam tubes for localised treatment of objects
- H01J37/317—Electron-beam or ion-beam tubes for localised treatment of objects for changing properties of the objects or for applying thin layers thereon, e.g. for ion implantation
- H01J37/3171—Electron-beam or ion-beam tubes for localised treatment of objects for changing properties of the objects or for applying thin layers thereon, e.g. for ion implantation for ion implantation
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J2237/00—Discharge tubes exposing object to beam, e.g. for analysis treatment, etching, imaging
- H01J2237/006—Details of gas supplies, e.g. in an ion source, to a beam line, to a specimen or to a workpiece
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
- H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
- H01L21/04—Manufacture or treatment of semiconductor devices or of parts thereof the devices having at least one potential-jump barrier or surface barrier, e.g. PN junction, depletion layer or carrier concentration layer
- H01L21/18—Manufacture or treatment of semiconductor devices or of parts thereof the devices having at least one potential-jump barrier or surface barrier, e.g. PN junction, depletion layer or carrier concentration layer the devices having semiconductor bodies comprising elements of Group IV of the Periodic System or AIIIBV compounds with or without impurities, e.g. doping materials
- H01L21/26—Bombardment with radiation
- H01L21/263—Bombardment with radiation with high-energy radiation
- H01L21/265—Bombardment with radiation with high-energy radiation producing ion implantation
- H01L21/26506—Bombardment with radiation with high-energy radiation producing ion implantation in group IV semiconductors
- H01L21/26513—Bombardment with radiation with high-energy radiation producing ion implantation in group IV semiconductors of electrically active species
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
- H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
- H01L21/04—Manufacture or treatment of semiconductor devices or of parts thereof the devices having at least one potential-jump barrier or surface barrier, e.g. PN junction, depletion layer or carrier concentration layer
- H01L21/18—Manufacture or treatment of semiconductor devices or of parts thereof the devices having at least one potential-jump barrier or surface barrier, e.g. PN junction, depletion layer or carrier concentration layer the devices having semiconductor bodies comprising elements of Group IV of the Periodic System or AIIIBV compounds with or without impurities, e.g. doping materials
- H01L21/26—Bombardment with radiation
- H01L21/263—Bombardment with radiation with high-energy radiation
- H01L21/265—Bombardment with radiation with high-energy radiation producing ion implantation
- H01L21/2658—Bombardment with radiation with high-energy radiation producing ion implantation of a molecular ion, e.g. decaborane
Definitions
- the present disclosure relates to semiconductor fabrication generally and ion beam generation in particular.
- Extrinsic semiconductors rely on dopants to provide a desired density of charge carriers.
- Dopant implantation is a major step in extrinsic semiconductor processing.
- an ion beam implants dopants into the wafer.
- Chemical species are deposited into semiconductor wafers by bombarding the substrate with energized ions. The amount of dopant deposited controls the type and conductivity of the resulting semiconductor. The ability to control the active device characteristics depends on the ability to deposit a predetermined dosage of a dopant uniformly throughout the various regions of the substrate.
- the implanter includes an ion source head, which generates the energized ions. It has been observed experimentally that the source head lifetime was shorter when used to implant Ge than other species, such as As, B, BF 2 , and P. More severe tool symptoms were observed during Germanium (Ge) implantation, resulting in worse source head condition and poor beam uniformity and stability. The inventors observed a high current implanter experience poor source head life time during Ge implantation—as short as 10 hours mean time between failure. It was observed that WF 6 whiskers were deposited on the aperture of the arc chamber of the ion source, degrading beam uniformity. The whiskers were the result of the tungsten material of the arc chamber wall being consumed in the following reaction:
- the beam uniformity (measured as a ratio of the standard deviation of the beam current divided by the maximum beam current value) across the length of 300 mm was observed to be about 0.84%.
- Perel et al. describes an ion implanter system, an ion source therefor and a method for operating the ion source.
- Perel et al. propose diluting the dopant gas with a dilutant gas containing 70% xenon (Xe) and 30% hydrogen (H 2 ).
- the dilutant gas made up 10% to 40% of the total gas in the arc chamber with a preferred composition of 20% dilutant and 80% dopant gas.
- Perel et al. report reduced weight gain of ion source components with this combination.
- a method comprises supplying a dopant gas in an arc chamber of an ion source.
- a dilutant is supplied in the arc chamber to dilute the dopant gas.
- the dilutant comprises about 98.5 wt. % xenon and 1.5 wt. % hydrogen.
- An ion beam is generated from the diluted dopant gas using the ion source.
- a method comprises supplying a dopant gas in an arc chamber of an ion source.
- a dilutant is supplied in the arc chamber to dilute the dopant gas.
- the dilutant comprises xenon and hydrogen.
- the diluted dopant gas comprises about 44 wt % dopant gas and about 56 wt % dilutant.
- An ion beam is generated from the diluted dopant gas using the ion source.
- an apparatus comprises an ion source for generating an ion beam.
- the ion source including an arc chamber.
- a diluted dopant means is provided for supplying a dopant gas to the arc chamber and for supplying a dilutant to dilute the dopant gas in the arc chamber.
- the diluted dopant gas is usable for generating the ion beam using the ion source.
- the dilutant comprises xenon and hydrogen.
- a controller is provided for controlling the dopant supply means and the dilutant supply means, so that the diluted dopant gas comprises about 44 wt % dopant gas and about 56 wt % dilutant.
- FIG. 1 is a schematic diagram of an ion source of an ion implanter system.
- FIG. 2 is a schematic diagram of the ion source of FIG. 1 with an optional gas feed.
- FIG. 3 is a variation of the ion source of FIG. 1 , having separate gas supply lines to the arc chamber.
- FIG. 4 is a flow chart of a first exemplary method.
- FIG. 5 is a flow chart of a second exemplary method.
- FIG. 1 is a schematic diagram of an apparatus according to one embodiment.
- the apparatus comprises an ion source 100 for generating an ion beam 124 .
- the ion source 100 includes an arc chamber 102 .
- the arc chamber 102 has an anode 104 and a heated cathode 106 .
- a filament power supply 120 provides power to heat the cathode 106 , causing acceleration of electrons toward the cathode 106 .
- An arc power supply 118 supplies the power to the chamber housing to accelerate electrons emitted by the cathode 106 into a plasma.
- a magnet or set of magnets 126 N, 126 S is provided to establish a magnetic field for the ion beam formation.
- the arc chamber has an aperture 114 , through which the ion beam passes.
- An extraction electrode 122 shapes and defines the ion beam 124 as it leaves the ion source 100 .
- Gas 128 is supplied to the arc chamber from a gas source 112 .
- the gas source is a reservoir 112 containing the dopant mixed with the dilutant gas.
- the exemplary apparatus 100 of FIG. 1 includes reservoir 112 containing a mixture of dopant gas (e.g., GeF 4 ) and dilutant gas (e.g., xenon and hydrogen).
- the dopant gas may comprise Ge, As, B, BF 2 , P, or other species to be implanted in semiconductor substrates.
- the dopant gas is GeF 4 .
- the dilutant gas may be purchased or otherwise provided in a vessel, such as a bottle.
- the vessel may by a gas bottle or container sold by Praxair Corporation of Danbury, Conn.
- Such product may be loaded with nominally equal parts by volume of xenon and hydrogen, and may contain about 250 grams Xe and about 4 grams H 2 , or 98.4 wt. % Xe and 1.6 wt. % H 2 .
- the dilutant may vary from about 48% to about 50 xenon molecules and from about 50% to about 52% hydrogen molecules. In one example, the molecules in the dilutant are 48.6% Xe molecules and 51.4% H 2 . In other embodiments, the dilutant may include a different inert gas, such as Argon.
- the apparatus 100 may include a diluted dopant means for supplying diluted dopant to the arc chamber 102 under automatic control.
- FIG. 2 shows the apparatus of FIG. 1 , with an optional automatic feed added. Identical items in FIGS. 1 and 2 have the same reference numerals.
- the diluted dopant means includes a dopant supply means for supplying dopant gas to the arc chamber 102 via a mixing chamber.
- the apparatus 100 also includes a dilutant supply means for supplying a dilutant to the arc chamber 102 via the mixing chamber 112 , to dilute the dopant gas.
- a dopant gas and dilutant gas are mixed in the mixing chamber or reservoir 112 and the diluted dopant gas is provided at the inlet of the arc chamber 102 .
- the arc chamber has separate inlets for receiving the dopant gas and at least one dilutant gas, directly from respective gas feeds.
- the arc chamber may have an inlet for receiving a dopant gas and two additional inlets for receiving dilutant gases, which are mixed with the dopant in the arc chamber.
- the dilutant supply means include a dilutant gas supply 130 and a dilutant gas flow control valve 134 operated under control of a controller 110 .
- the dilutant gas supply 130 contains the dilutant composition to be used to dilute the dopant gas for ion generation.
- the dilutant is a mixture of xenon gas and hydrogen in a 1:2 atomic ratio (i.e., one molecule of xenon per molecule of H 2 ), such as a bottled mixture supplied by the Praxair Corporation of Danbury, Conn.
- the xenon and hydrogen gases are supplied to dilutant gas supply 130 in approximately equal volumes.
- the dopant supply means may include a dopant reservoir 132 and a control valve 136 operated under control of the controller 110 .
- the dopant gas may comprise Ge, As, B, BF 2 , P, or other species to be implanted in semiconductor substrates. In one embodiment, the dopant gas is GeF 4 .
- the controller 110 controls the flow control valve 136 of the dopant supply means and the flow control valve 134 of the dilutant supply means, so that the diluted dopant gas in mixing chamber 112 comprises about 44 wt % dopant gas and about 56 wt % dilutant.
- the controller 110 also controls an inlet valve 108 that controls flow of the diluted dopant gas from the mixing chamber 112 into the arc chamber 102 .
- the controller 110 is a programmable logic controller (PLC).
- PLC programmable logic controller
- the controller 110 provides signals (e.g., analog signals) to operate the flow control valves 108 , 134 and 136 , and may collect flow rate data.
- the controller 110 may optionally be coupled to a processor (not shown) that provides a human-machine interface to permit programming of the controller 110 using a high level language.
- the controller 110 may be a microcontroller or processor with an interface card to permit issuance of control signals for operating the valves 108 , 134 and 136 .
- the gas source includes a plurality of reservoirs or conduits that feed individual constituents directly into the arc chamber 102 to be mixed within the chamber.
- FIG. 3 shows an alternative embodiment in which the reservoir 112 is omitted, and the dilutant supply means and the dopant supply means have separate conduits for supplying the dilutant and dopant, respectively, to the arc chamber 202 .
- Items in FIG. 3 that are the same as those in FIG. 2 are indicated by a reference numeral having the same two least significant digits, but increased by 100.
- the dopant supply means include a dopant supply 212 a, with an associated control valve 208 a.
- the dilutant supply means include a xenon supply 212 b, with an associated control valve 208 b, and a hydrogen supply 212 c with an associated control valve 208 c.
- the Control valves 208 a to 208 c are all fluidly coupled to the arc chamber 202 to deliver the constituents directly to the arc chamber 202 where they are mixed.
- the controller 210 is configured to control the control valves 208 b and 208 c to dispense substantially equal volumes of xenon and hydrogen into the arc chamber 202 (assuming the xenon and hydrogen are at equal temperatures and pressures).
- the controller 210 is also configured to control the valve 208 a to dispense a volume of GF 4 gas that is 0.7 times the volume of xenon dispensed (assuming the xenon and GF 4 are at equal temperatures and pressures).
- the controller 210 controls the valves 208 a - 208 c to dispense substantially equal numbers of xenon and hydrogen molecules, and a number of molecules of GF 4 that is about 0.7 times the number of molecules of xenon.
- FIG. 4 is a flow chart of an exemplary method of using the apparatus of FIG. 2 or the apparatus of FIG. 3 .
- a dopant gas is supplied to an arc chamber 102 of an ion source 100 .
- the dopant may comprise any species suitable for implantation in a semiconductor wafer.
- the dopant gas may also comprise a halogen, such as fluorine.
- a GeF4 gas is supplied to the arc chamber 102 .
- a dilutant is supplied to the arc chamber to dilute the dopant gas.
- the dilutant comprises about 98.5 wt. % xenon and about 1.5 wt. % hydrogen (or approximately equal volumes of xenon and hydrogen at the same temperature and pressure).
- the dilutant may be input from the same inlet as the dopant or from a separate inlet.
- an ion beam is generated from the diluted dopant gas using the ion source.
- Improved ion source mean time between failure (MTBF) is provided using this dilutant gas.
- FIG. 5 is a flow chart of an exemplary method of using the apparatus
- a dopant gas is supplied to an arc chamber 102 of an ion source 100 .
- a dilutant is supplied to the arc chamber to dilute the dopant gas.
- the dilutant comprises xenon and hydrogen.
- the diluted dopant gas comprises between 40 wt % and 50 wt % dopant gas and between 50 wt % and 60 wt % dilutant.
- the diluted dopant gas comprises about 44 wt % dopant gas and about 56 wt % dilutant.
- the dilutant may be input from the same inlet as the dopant or from a separate inlet.
- an ion beam is generated from the diluted dopant gas using the ion source.
- Improved ion source mean time between failure (MTBF) is provided using this ratio of dilutant to dopant gas.
- Table 1 provides data from two tests that were conducted using GeF 4 as the dopant gas and a mixture of Xe and H 2 as a dilutant.
- “Condition 1” represents a gas mixture as specified in U.S. Patent Application Publication No. US 2008/0179545 A1. The ion source was capable of providing an ion beam for a sufficient period to perform implantation on 869 wafers.
- “Condition 2” represents a mixture with 56% dilutant gas as described herein. an ion source of the same type used in Condition 1 could now process 1134 wafers under the parameters of condition 2,
Abstract
Description
- This application claims the benefit of U.S. Provisional Application No. 61/143,492, filed Jan. 9, 2009, which application is expressly incorporated by reference herein in its entirety.
- The present disclosure relates to semiconductor fabrication generally and ion beam generation in particular.
- Extrinsic semiconductors rely on dopants to provide a desired density of charge carriers. Dopant implantation is a major step in extrinsic semiconductor processing. In conventional CMOS manufacturing, an ion beam implants dopants into the wafer. Chemical species are deposited into semiconductor wafers by bombarding the substrate with energized ions. The amount of dopant deposited controls the type and conductivity of the resulting semiconductor. The ability to control the active device characteristics depends on the ability to deposit a predetermined dosage of a dopant uniformly throughout the various regions of the substrate.
- Commercially available ion implanter systems are used to perform implantation. The implanter includes an ion source head, which generates the energized ions. It has been observed experimentally that the source head lifetime was shorter when used to implant Ge than other species, such as As, B, BF2, and P. More severe tool symptoms were observed during Germanium (Ge) implantation, resulting in worse source head condition and poor beam uniformity and stability. The inventors observed a high current implanter experience poor source head life time during Ge implantation—as short as 10 hours mean time between failure. It was observed that WF6 whiskers were deposited on the aperture of the arc chamber of the ion source, degrading beam uniformity. The whiskers were the result of the tungsten material of the arc chamber wall being consumed in the following reaction:
- The beam uniformity (measured as a ratio of the standard deviation of the beam current divided by the maximum beam current value) across the length of 300 mm was observed to be about 0.84%.
- U.S. Patent Application Publication No. US 2008/0179545 A1, published Jul. 31, 2008 and entitled “Technique for Improving the Performance and Extending the Lifetime of an Ion Source with Gas Dilution” (“Perel et al.) is incorporated by reference herein in its entirety. Perel et al. describes an ion implanter system, an ion source therefor and a method for operating the ion source.
- Perel et al. propose diluting the dopant gas with a dilutant gas containing 70% xenon (Xe) and 30% hydrogen (H2). The dilutant gas made up 10% to 40% of the total gas in the arc chamber with a preferred composition of 20% dilutant and 80% dopant gas. Perel et al. report reduced weight gain of ion source components with this combination.
- Improved methods are desired.
- In some embodiments, a method comprises supplying a dopant gas in an arc chamber of an ion source. A dilutant is supplied in the arc chamber to dilute the dopant gas. The dilutant comprises about 98.5 wt. % xenon and 1.5 wt. % hydrogen. An ion beam is generated from the diluted dopant gas using the ion source.
- In some embodiments, a method comprises supplying a dopant gas in an arc chamber of an ion source. A dilutant is supplied in the arc chamber to dilute the dopant gas. The dilutant comprises xenon and hydrogen. The diluted dopant gas comprises about 44 wt % dopant gas and about 56 wt % dilutant. An ion beam is generated from the diluted dopant gas using the ion source.
- In some embodiments, an apparatus comprises an ion source for generating an ion beam. The ion source including an arc chamber. A diluted dopant means is provided for supplying a dopant gas to the arc chamber and for supplying a dilutant to dilute the dopant gas in the arc chamber. The diluted dopant gas is usable for generating the ion beam using the ion source. The dilutant comprises xenon and hydrogen. A controller is provided for controlling the dopant supply means and the dilutant supply means, so that the diluted dopant gas comprises about 44 wt % dopant gas and about 56 wt % dilutant.
-
FIG. 1 is a schematic diagram of an ion source of an ion implanter system. -
FIG. 2 is a schematic diagram of the ion source ofFIG. 1 with an optional gas feed. -
FIG. 3 is a variation of the ion source ofFIG. 1 , having separate gas supply lines to the arc chamber. -
FIG. 4 is a flow chart of a first exemplary method. -
FIG. 5 is a flow chart of a second exemplary method. - This description of the exemplary embodiments is intended to be read in connection with the accompanying drawings, which are to be considered part of the entire written description. In the description, relative terms such as “lower,” “upper,” “horizontal,” “vertical,” “above,” “below,” “up,” “down,” “top” and “bottom” as well as derivative thereof (e.g., “horizontally,” “downwardly,” “upwardly,” etc.) should be construed to refer to the orientation as then described or as shown in the drawing under discussion. These relative terms are for convenience of description and do not require that the apparatus be constructed or operated in a particular orientation. Terms concerning attachments, coupling and the like, such as “connected” and “interconnected,” refer to a relationship wherein structures are secured or attached to one another either directly or indirectly through intervening structures, as well as both movable or rigid attachments or relationships, unless expressly described otherwise.
-
FIG. 1 is a schematic diagram of an apparatus according to one embodiment. The apparatus comprises anion source 100 for generating anion beam 124. Theion source 100 includes anarc chamber 102. Thearc chamber 102 has ananode 104 and aheated cathode 106. Afilament power supply 120 provides power to heat thecathode 106, causing acceleration of electrons toward thecathode 106. Anarc power supply 118 supplies the power to the chamber housing to accelerate electrons emitted by thecathode 106 into a plasma. A magnet or set ofmagnets aperture 114, through which the ion beam passes. Anextraction electrode 122 shapes and defines theion beam 124 as it leaves theion source 100. -
Gas 128 is supplied to the arc chamber from agas source 112. In some embodiments, the gas source is areservoir 112 containing the dopant mixed with the dilutant gas. - The
exemplary apparatus 100 ofFIG. 1 includesreservoir 112 containing a mixture of dopant gas (e.g., GeF4) and dilutant gas (e.g., xenon and hydrogen). The dopant gas may comprise Ge, As, B, BF2, P, or other species to be implanted in semiconductor substrates. In one embodiment, the dopant gas is GeF4. The dilutant gas may be purchased or otherwise provided in a vessel, such as a bottle. For example, the vessel may by a gas bottle or container sold by Praxair Corporation of Danbury, Conn. Such product may be loaded with nominally equal parts by volume of xenon and hydrogen, and may contain about 250 grams Xe and about 4 grams H2, or 98.4 wt. % Xe and 1.6 wt. % H2. The dilutant may vary from about 48% to about 50 xenon molecules and from about 50% to about 52% hydrogen molecules. In one example, the molecules in the dilutant are 48.6% Xe molecules and 51.4% H2. In other embodiments, the dilutant may include a different inert gas, such as Argon. - Optionally, the
apparatus 100 may include a diluted dopant means for supplying diluted dopant to thearc chamber 102 under automatic control.FIG. 2 shows the apparatus ofFIG. 1 , with an optional automatic feed added. Identical items inFIGS. 1 and 2 have the same reference numerals. - In the embodiment of
FIG. 2 , the diluted dopant means includes a dopant supply means for supplying dopant gas to thearc chamber 102 via a mixing chamber. Theapparatus 100 also includes a dilutant supply means for supplying a dilutant to thearc chamber 102 via the mixingchamber 112, to dilute the dopant gas. In the embodiment ofFIG. 2 , a dopant gas and dilutant gas are mixed in the mixing chamber orreservoir 112 and the diluted dopant gas is provided at the inlet of thearc chamber 102. In other embodiments (described below with reference toFIG. 3 ), the arc chamber has separate inlets for receiving the dopant gas and at least one dilutant gas, directly from respective gas feeds. For example, the arc chamber may have an inlet for receiving a dopant gas and two additional inlets for receiving dilutant gases, which are mixed with the dopant in the arc chamber. - Referring again to
FIG. 2 , the dilutant supply means include adilutant gas supply 130 and a dilutant gasflow control valve 134 operated under control of acontroller 110. Thedilutant gas supply 130 contains the dilutant composition to be used to dilute the dopant gas for ion generation. In some embodiments, the dilutant is a mixture of xenon gas and hydrogen in a 1:2 atomic ratio (i.e., one molecule of xenon per molecule of H2), such as a bottled mixture supplied by the Praxair Corporation of Danbury, Conn. Alternatively, if supplied separately at the same temperature and pressure, the xenon and hydrogen gases are supplied todilutant gas supply 130 in approximately equal volumes. - Similarly, the dopant supply means may include a
dopant reservoir 132 and acontrol valve 136 operated under control of thecontroller 110. The dopant gas may comprise Ge, As, B, BF2, P, or other species to be implanted in semiconductor substrates. In one embodiment, the dopant gas is GeF4. - The
controller 110 controls theflow control valve 136 of the dopant supply means and theflow control valve 134 of the dilutant supply means, so that the diluted dopant gas in mixingchamber 112 comprises about 44 wt % dopant gas and about 56 wt % dilutant. Thecontroller 110 also controls aninlet valve 108 that controls flow of the diluted dopant gas from the mixingchamber 112 into thearc chamber 102. - In some embodiments, the
controller 110 is a programmable logic controller (PLC). Thecontroller 110 provides signals (e.g., analog signals) to operate theflow control valves controller 110 may optionally be coupled to a processor (not shown) that provides a human-machine interface to permit programming of thecontroller 110 using a high level language. In other embodiments, thecontroller 110 may be a microcontroller or processor with an interface card to permit issuance of control signals for operating thevalves - In other embodiments, the gas source includes a plurality of reservoirs or conduits that feed individual constituents directly into the
arc chamber 102 to be mixed within the chamber. - For example,
FIG. 3 shows an alternative embodiment in which thereservoir 112 is omitted, and the dilutant supply means and the dopant supply means have separate conduits for supplying the dilutant and dopant, respectively, to thearc chamber 202. Items inFIG. 3 that are the same as those inFIG. 2 are indicated by a reference numeral having the same two least significant digits, but increased by 100. - In
FIG. 3 , the dopant supply means include adopant supply 212 a, with an associatedcontrol valve 208 a. The dilutant supply means include axenon supply 212 b, with an associatedcontrol valve 208 b, and ahydrogen supply 212 c with an associatedcontrol valve 208 c. TheControl valves 208 a to 208 c are all fluidly coupled to thearc chamber 202 to deliver the constituents directly to thearc chamber 202 where they are mixed. For a given period of time, thecontroller 210 is configured to control thecontrol valves controller 210 is also configured to control thevalve 208 a to dispense a volume of GF4 gas that is 0.7 times the volume of xenon dispensed (assuming the xenon and GF4 are at equal temperatures and pressures). In other words, thecontroller 210 controls the valves 208 a-208 c to dispense substantially equal numbers of xenon and hydrogen molecules, and a number of molecules of GF4 that is about 0.7 times the number of molecules of xenon. -
FIG. 4 is a flow chart of an exemplary method of using the apparatus ofFIG. 2 or the apparatus ofFIG. 3 . - At
step 400, a dopant gas is supplied to anarc chamber 102 of anion source 100. The dopant may comprise any species suitable for implantation in a semiconductor wafer. For example, Ge, As, B, BF2, and P. The dopant gas may also comprise a halogen, such as fluorine. In one embodiment, a GeF4 gas is supplied to thearc chamber 102. - At
step 402, a dilutant is supplied to the arc chamber to dilute the dopant gas. The dilutant comprises about 98.5 wt. % xenon and about 1.5 wt. % hydrogen (or approximately equal volumes of xenon and hydrogen at the same temperature and pressure). The dilutant may be input from the same inlet as the dopant or from a separate inlet. - At
step 404, an ion beam is generated from the diluted dopant gas using the ion source. Improved ion source mean time between failure (MTBF) is provided using this dilutant gas. -
FIG. 5 is a flow chart of an exemplary method of using the apparatus - At
step 500, a dopant gas is supplied to anarc chamber 102 of anion source 100. - At
step 502, a dilutant is supplied to the arc chamber to dilute the dopant gas. The dilutant comprises xenon and hydrogen. The diluted dopant gas comprises between 40 wt % and 50 wt % dopant gas and between 50 wt % and 60 wt % dilutant. In one embodiment, the diluted dopant gas comprises about 44 wt % dopant gas and about 56 wt % dilutant. The dilutant may be input from the same inlet as the dopant or from a separate inlet. - At
step 504, an ion beam is generated from the diluted dopant gas using the ion source. Improved ion source mean time between failure (MTBF) is provided using this ratio of dilutant to dopant gas. - Table 1 provides data from two tests that were conducted using GeF4 as the dopant gas and a mixture of Xe and H2 as a dilutant. “
Condition 1” represents a gas mixture as specified in U.S. Patent Application Publication No. US 2008/0179545 A1. The ion source was capable of providing an ion beam for a sufficient period to perform implantation on 869 wafers. “Condition 2” represents a mixture with 56% dilutant gas as described herein. an ion source of the same type used inCondition 1 could now process 1134 wafers under the parameters of condition 2, -
TABLE 1 Condition 1Condition 2 Gas Gas Flow (sccm) Gas Flow (sccm) GeF4 (Process gas) 1.3 1 Xe/H2 (Dilution Gas) 0.3 1.3 Flow Ratio: Xe/H2/(GeF4 + 18.75% 56.52% Xe/H2) Continually Run Ge IMP (Wafers) 869 1134 - Although the invention has been described in terms of exemplary embodiments, it is not limited thereto. Rather, the appended claims should be construed broadly, to include other variants and embodiments of the invention, which may be made by those skilled in the art without departing from the scope and range of equivalents of the invention.
Claims (20)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/416,725 US7973293B2 (en) | 2009-01-09 | 2009-04-01 | Implantation quality improvement by xenon/hydrogen dilution gas |
CN2010100002511A CN101777490B (en) | 2009-01-09 | 2010-01-06 | Method forming doped layer on wafer |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14349209P | 2009-01-09 | 2009-01-09 | |
US12/416,725 US7973293B2 (en) | 2009-01-09 | 2009-04-01 | Implantation quality improvement by xenon/hydrogen dilution gas |
Publications (2)
Publication Number | Publication Date |
---|---|
US20100176306A1 true US20100176306A1 (en) | 2010-07-15 |
US7973293B2 US7973293B2 (en) | 2011-07-05 |
Family
ID=42318381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/416,725 Expired - Fee Related US7973293B2 (en) | 2009-01-09 | 2009-04-01 | Implantation quality improvement by xenon/hydrogen dilution gas |
Country Status (2)
Country | Link |
---|---|
US (1) | US7973293B2 (en) |
CN (1) | CN101777490B (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8237134B2 (en) | 2010-02-26 | 2012-08-07 | Advanced Technology Materials, Inc. | Method and apparatus for enhanced lifetime and performance of ion source in an ion implantation system |
US20140151572A1 (en) * | 2012-12-03 | 2014-06-05 | Advanced Ion Beam Technology, Inc. | Gas mixture method and apparatus for generating ion beam |
US8779383B2 (en) | 2010-02-26 | 2014-07-15 | Advanced Technology Materials, Inc. | Enriched silicon precursor compositions and apparatus and processes for utilizing same |
US20160086763A1 (en) * | 2012-08-22 | 2016-03-24 | Infineon Technologies Ag | Ion source devices and methods |
JP2016511504A (en) * | 2012-12-21 | 2016-04-14 | プラクスエア・テクノロジー・インコーポレイテッド | Storage and subatmospheric pressure delivery of dopant compositions for carbon ion implantation |
US11062906B2 (en) | 2013-08-16 | 2021-07-13 | Entegris, Inc. | Silicon implantation in substrates and provision of silicon precursor compositions therefor |
JP2021524648A (en) * | 2018-05-17 | 2021-09-13 | インテグリス・インコーポレーテッド | A mixture of germanium tetrafluoride and hydrogen for ion implantation systems |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9922800B2 (en) | 2014-01-17 | 2018-03-20 | Taiwan Semiconductor Manufacturing Co., Ltd | System and method for generating ions in an ion source |
US9570271B2 (en) | 2014-03-03 | 2017-02-14 | Praxair Technology, Inc. | Boron-containing dopant compositions, systems and methods of use thereof for improving ion beam current and performance during boron ion implantation |
KR20170004381A (en) | 2015-07-02 | 2017-01-11 | 삼성전자주식회사 | Methods of manufacturing semiconductor devices including impurity regions |
US9741537B1 (en) | 2016-02-19 | 2017-08-22 | Taiwan Semiconductor Manufacturing Co., Ltd. | Method and apparatus for supplying ion beam in ion implantation process |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080179545A1 (en) * | 2007-01-25 | 2008-07-31 | Varian Semiconductor Equipment Associates | Technique for Improving the Performance and Extending the Lifetime of an Ion Source with Gas Dilution |
-
2009
- 2009-04-01 US US12/416,725 patent/US7973293B2/en not_active Expired - Fee Related
-
2010
- 2010-01-06 CN CN2010100002511A patent/CN101777490B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080179545A1 (en) * | 2007-01-25 | 2008-07-31 | Varian Semiconductor Equipment Associates | Technique for Improving the Performance and Extending the Lifetime of an Ion Source with Gas Dilution |
US7586109B2 (en) * | 2007-01-25 | 2009-09-08 | Varian Semiconductor Equipment Associates, Inc. | Technique for improving the performance and extending the lifetime of an ion source with gas dilution |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9171725B2 (en) | 2010-02-26 | 2015-10-27 | Entegris, Inc. | Enriched silicon precursor compositions and apparatus and processes for utilizing same |
US8399865B2 (en) | 2010-02-26 | 2013-03-19 | Advanced Technology Materials, Inc. | Method and apparatus for enhanced lifetime and performance of ion source in an ion implantation system |
US9754786B2 (en) | 2010-02-26 | 2017-09-05 | Entegris, Inc. | Method and apparatus for enhanced lifetime and performance of ion source in an ion implantation system |
US8779383B2 (en) | 2010-02-26 | 2014-07-15 | Advanced Technology Materials, Inc. | Enriched silicon precursor compositions and apparatus and processes for utilizing same |
US8785889B2 (en) | 2010-02-26 | 2014-07-22 | Advanced Technology Materials, Inc. | Method and apparatus for enhanced lifetime and performance of ion source in an ion implantation system |
US9012874B2 (en) | 2010-02-26 | 2015-04-21 | Entegris, Inc. | Method and apparatus for enhanced lifetime and performance of ion source in an ion implantation system |
US8237134B2 (en) | 2010-02-26 | 2012-08-07 | Advanced Technology Materials, Inc. | Method and apparatus for enhanced lifetime and performance of ion source in an ion implantation system |
US20160086763A1 (en) * | 2012-08-22 | 2016-03-24 | Infineon Technologies Ag | Ion source devices and methods |
US10068743B2 (en) * | 2012-08-22 | 2018-09-04 | Infineon Technologies Ag | Ion source devices and methods |
US9147550B2 (en) * | 2012-12-03 | 2015-09-29 | Advanced Ion Beam Technology, Inc. | Gas mixture method and apparatus for generating ion beam |
US20140151572A1 (en) * | 2012-12-03 | 2014-06-05 | Advanced Ion Beam Technology, Inc. | Gas mixture method and apparatus for generating ion beam |
JP2016511504A (en) * | 2012-12-21 | 2016-04-14 | プラクスエア・テクノロジー・インコーポレイテッド | Storage and subatmospheric pressure delivery of dopant compositions for carbon ion implantation |
US20170032967A1 (en) * | 2012-12-21 | 2017-02-02 | Praxair Technology, Inc. | Storage and sub-atmospheric delivery of dopant compositions for carbon ion implantation |
US11062906B2 (en) | 2013-08-16 | 2021-07-13 | Entegris, Inc. | Silicon implantation in substrates and provision of silicon precursor compositions therefor |
JP2021524648A (en) * | 2018-05-17 | 2021-09-13 | インテグリス・インコーポレーテッド | A mixture of germanium tetrafluoride and hydrogen for ion implantation systems |
US11299802B2 (en) | 2018-05-17 | 2022-04-12 | Entegris, Inc. | Germanium tetraflouride and hydrogen mixtures for an ion implantation system |
US11827973B2 (en) | 2018-05-17 | 2023-11-28 | Entegris, Inc. | Germanium tetraflouride and hydrogen mixtures for an ion implantation system |
Also Published As
Publication number | Publication date |
---|---|
US7973293B2 (en) | 2011-07-05 |
CN101777490B (en) | 2011-12-28 |
CN101777490A (en) | 2010-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7973293B2 (en) | Implantation quality improvement by xenon/hydrogen dilution gas | |
US9754786B2 (en) | Method and apparatus for enhanced lifetime and performance of ion source in an ion implantation system | |
CN106062918B (en) | Boron doped agent composition makes the system and method for using it to improve boron ion injection period ion beam current and performance | |
TWI788551B (en) | Germanium tetraflouride and hydrogen mixtures for an ion implantation system and an ion implantation method using the same | |
JP2012511104A (en) | Excitation gas injection for ion implantation control | |
TW201316373A (en) | Technique for ion implanting a target | |
TWI594301B (en) | Ion implantation method and ion implanter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD., TAIW Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIN, YU-PENG;YOU, WEI-MING;DENG, RUEY-YONG;AND OTHERS;SIGNING DATES FROM 20090709 TO 20090722;REEL/FRAME:023073/0150 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
LAPS | Lapse for failure to pay maintenance fees |
Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20190705 |